
HE4 Biomarker and Ovarian Cancer Screening
Ovarian cancer remains one of the most challenging gynaecological conditions to detect at an early stage, largely because its symptoms can be subtle and overlap with many other health concerns. The **HE4 biomarker** — Human Epididymis Protein 4 — has emerged as an important tool in ovarian cancer screening blood tests, offering additional clinical insight when used alongside other markers. For women in London seeking proactive, private health screening, understanding what the HE4 test measures and what it can suggest is an empowering first step.






